// App-Quantinova.ai

3397 : Comparison Of Intravenous With Oral Busulfan In Allogeneic Hematopoietic Stem Cell Transplantation With Myeloablative Conditioning Regimens For Pediatric Acute Leukemia

Researchers

Presenter

  • Motohiro Kato

Principal Investigators

  • Yoshiyuki Takahashi

  • Daisuke Tomizawa

  • Hisashi Sakamaki

  • Hiromasa Yabe

  • Keisei Kawa

  • Ritsuro Suzuki

  • Kazuko Kudo

  • Koji Kato

  • Yasuhiro Okamoto

  • Jiro Inagaki

  • Katsuyoshi Koh

  • Atsushi Ogawa

  • Keiko Okada

  • Yuko Cho

  • Junko Takita

  • Hiroaki Goto

Medical Centers

  • Department of Pathology, Niigata Cancer Center Hospital, Niigata City, Japan

  • Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Tokyo, Japan

  • Department of Hematology and Oncology, Childrens Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya,

  • The University of Tokyo, Tokyo, Japan

  • Department of HSCT Data Management/Biostatistics, Nagoya University Graduate School of Medicine, Nagoya, Japan

  • Department of Radiology, Okayama University Graduate School of Medicine, Okayama, Japan

  • Division of Leukemia and Lymphoma, Childrens Cancer Center, National Center for Child Health and Development, Tokyo, Japan

  • Pediatrics, Hokkaido University Hosoital, Sapporo, Japan

  • Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

  • Department of Clinical Research, National Kyushu Cancer Center, Fukuoka, Japan

  • Departments of Surgery, Fujita Health University School of Medicine, Toyoake, Japan

  • Higashiosaka City General Hospital, Osaka, Japan

  • Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan

  • Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine, Isehara, Japan

  • Department of Hematology/Oncology, Saitama Childrens Medical Center, Saitama, Japan

  • Department of Hematology/Oncology, Saitama Childrens Medical Center, Saitama, Japan

  • Haematology/Oncology, Osaka Medical Center And Research Institute For Maternal And Child Health, Izumi, Osaka, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

  • Acute Leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Busulfan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved